The Company's investment objective is to generate consistent long-term capital appreciation with low volatility and little correlation with the general equity and bond markets through a portfolio having a diversified risk profile. The Company seeks to achieve this through investment in an actively managed portfolio of hedge funds diversified by investment strategy, style and manager. The Company’s shares are denominated in Sterling, Euros, and US Dollars and the Company implements a hedging policy to protect the Sterling and Euro value of its US Dollar denominated investments.
Manager
Dexion Capital (Guernsey) Limited
Investment Adviser
Aurora Investment Management L.L.C.
Investment Consultant
Dexion Capital plc
Total Net Assets (as at 30-Jun-10)
£868.25M
| Last | Bid | Offer | NAV** | |
| GBX | 138.800 | 138.800 | 139.200 | 156.000 |
| EUR | 1.780 | 1.755 | 1.785 | 2.029 |
| USD | 2.418 | 2.400 | 2.420 | 2.751 |
As at 13:20:01 31-Jul-2010
*Delayed by 15 minutes
**NAV estimated as at 23-Jul-10
Email
Telephone
+44 1481 743940
NAV/Performance
DAL Monthly Data.xls
Share Price
DAL Daily Shareprice.xls
| 30-Jun-10 |
June (%) |
YTD (%) |
ITD *¹(%) |
Volatility *¹(%) |
Sharpe *ˆ¹ |
|
| Dexion Absolute £ Share NAV | 155.47 | -0.77 | 0.72 | 6.31 | 7.50 | 0.31 |
| Dexion Absolute € Share NAV | 2.0226 | -0.90 | 0.23 | 1.99 | 10.09 | -0.07 |
| Dexion Absolute US$ Share NAV | 2.7432 | -0.84 | 0.44 | 4.36 | 7.64 | 0.17 |
| HFRI Fund of Funds Index (US$) | -0.70 | -1.03 | 4.12 | 5.87 | 0.26 | |
| MSCI World Index Gross (TR) (US$) | -3.43 | -9.56 | 6.33 | 16.20 | 0.23 | |
| JPM Global Gov’t Bond Index (TR) (US$) | 1.94 | 0.38 | 6.63 | 7.51 | 0.53 | |
* Annualised from inception date of DAB £, DAB €, and DAB US$, based on monthly data.
|
||||||
| Inception Date | Bloomberg | Reuters | Isin | Sedol | Total Net Assets | |
| £ | 19 Dec 2002 | DAB LN | DAB.L | GB0032287020 | 3228702 | £779.61M |
| € | 28 Jun 2005 | DABE LN | DABx.L | GB00B0FXK920 | B0FXK92 | €38.71M |
| US$ | 28 Jun 2005 | DABU LN | DABu.L | GB00B0FXL332 | B0FXL33 | US$85.25M |
Site issued and operated by Dexion Capital. Dexion Capital is registered in England and Wales under company number 4040660 and has its registered office at 9 Bridewell Place, London EC4V 6AW.
Dexion Capital is authorised and regulated by the Financial Services Authority and provides services and markets securities in the United Kingdom and certain E.U. and other non-U.S. jurisdictions. The contents of this site may only be accessed by certain categories of persons and are not available to all persons. Dexion closed-end funds are not registered under the U.S. Securities Act of 1933 or the Investment Company Act of 1940 and are not being offered or sold in the U.S.